Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
View graph of relations

Expertises

Crohn’s disease; ulcerative colitis; biologic therapy; Good Clinical Practice (GCP); experience in preparing and running a multicenter clinical study.

Main research areas

Optimizing infliximab therapy in patients with inflammatory bowel disease.

Current research

An investigator-initiated double-blind, randomized, placebo controlled, multicentre clinical trial with the aim to investigate if infliximab can safely and favourably be discontinued in patients with Crohn's disease, in sustained complete remission on infliximab maintenance therapy.

 

Potential conflicts of interest

Served as speaker for Janssen

ID: 44833319